Accuray Incorporated - Common Stock (ARAY)

0.8020
-0.0045 (-0.56%)
NASDAQ · Last Trade: Jan 27th, 1:39 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside
Medical technology, infection control systems, oncology radiotherapy solutions, and diagnostics innovation remain key healthcare growth themes heading into 2026—and CS Diagnostics Corp. (OTCQB: CSDX) is positioning itself at the intersection of both.
Via AB Newswire · January 14, 2026
Accuray Inc. (NASDAQ: ARAY) Leading the Way in Wednesday Trading Based on Percentage Gain
Accuray Incorporated (NASDAQ: ARAY) is one of today’s top gainers. The company’s shares are currently up 9.81% on the day to $2.85.
Via Investor Brand Network · October 4, 2023
Global Metastatic Cancer Treatment Market Size Is Forecasted To Reach $111.16 Million By 2027
Palm Beach, FL – November 3, 2021 – FinancialNewsMedia.com News Commentary – The metastatic cancer treatment systems market is observing high demand attributed to its increasing application in breast, lung, melanoma, prostate, and colorectal cancers. Factors such as increasing incidence of metastatic cancer, rising government initiatives to spread cancer awareness, increase in healthcare expenditure, and […]
Via FinancialNewsMedia · November 3, 2021